(Q37297852)

19 August 2017

1 reference

title

Chemotherapy of Schistosomiasis mansoni (English)

1 reference

19 August 2017

0 references

0 references

1 reference

N. Katz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A18911

17 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18911

17 October 2022

publication date

1 January 1977

1 reference

Advances in pharmacology and chemotherapy

19 August 2017

published in

1 reference

19 August 2017

volume

14

1 reference

19 August 2017

page(s)

1-70

1 reference

Schistosomiasis; intensive treatment with antimony

19 August 2017

cites work

17

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Preliminary field trials with M&B 2948A in Schistosoma haematobium infections in man

17 October 2022

19

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

An attempt to obtain infertile live worms in mice infected withSchistosoma mansoni

17 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Evaluation of the effect of mass chemotherapy with niridazole as a method of bilharziasis control in Iran

17 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthesis and schistosomicidal activity of 6-chloro-5-[[2-(diethylamino)ethyl]amino]-8-quinolinemethanol

17 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The incidence of natural diphtheria antitoxin in horses; its influence on the results of antigenic stimulus

17 October 2022

30

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The possible role of acetylcholine in Schistosoma mansoni

17 October 2022

33

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Infection of schistosomes with Gram-positive cocci

17 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosomicides. 1. Derivatives of 2-aminomethyl-1,2,3,4-tetrahydroquinoline

17 October 2022

36

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

DIET AND THERAPY IN BILHARZIA

17 October 2022

38

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

Molecular Pharmacology

41

9

311

Bennett

1973

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPEUTIC EFFECT OF ANTISCHISTOSOMAL DRUGS IN EXPERIMENTALLY INDUCED SCHISTOSOMA MANSONI INFECTIONS IN SWISS MICE AND SYRIAN HAMSTERS

17 October 2022

42

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosomicidal activity of lucanthone hydrochloride, hycanthone and their metabolites in mice and hamsters

17 October 2022

43

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A Comparison of Oral and Parenteral Activity of Hycanthone and Lucanthone in Experimental Infections with Schistosoma Mansoni

17 October 2022

44

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A new concentration technic for the demonstration of protozoa and helminth eggs in feces

17 October 2022

48

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Zinc Metabolism in Schistosomes

17 October 2022

51

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Chemotherapy of experimental schistosomiasis. I. Drug activity and mode of action of a new thioxanthone derivative

17 October 2022

60

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Nitroheterocycles. I. Nitrofuryl-substituted 3-amino-1,2,4-oxadiazoles and 5-amino-1,2,4-oxadiazoles.

17 October 2022

62

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

New Aminoquinoline with Schistosomicidal Activity

17 October 2022

63

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

An in vitro activity monitor for schistosomes: preliminary report.

17 October 2022

64

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

BIOLOGICAL DISPOSITION OF SOME ANTIMONYL ANTIBILHARZIAL DRUGS: SODIUM ANTIMONY-2,3-MESO-DIMERCAPTO-SUCCINATE (ASTIBAN) IN ANIMALS INFECTED WITH SCHISTOSOMA MANSONI.

17 October 2022

66

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A Method for Isolating Pure, Viable Schistosome Eggs from Host Tissues

17 October 2022

67

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The suppressive activity of sodium antimony dimercaptosuccinate (TWSB) in experimental infections with Schistosoma mansoni

17 October 2022

69

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Prophylactic and curative activities of antimony (3) dimercapto succinic acid in olive oil suspension, dicarbonic acid hydrazide, an organic phosphorus compound (Ronnel) and a nitro-thiazole derivative in rhesus monkeys experimentally infected with

17 October 2022

70

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The prophylactic and curative activity of sodium antimony dimercapto succinate (TWSb) in experimental infections with Schistosoma mansoni

17 October 2022

71

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosoma mansoni: Glycogen content and utilization of glucose, pyruvate, glutamate, and citric acid cycle intermediates by cercariae and schistosomules

17 October 2022

72

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Metabolism of parasitic helminths

17 October 2022

74

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Carbohydrate metabolism of schistosoma mansoni

17 October 2022

75

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Acetylcholinesterase activity of Schistosoma mansoni

17 October 2022

76

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Mechanisms of action of schistosomicidal agents

17 October 2022

77

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Some biochemical effects of anthelmintic drugs

17 October 2022

80

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Dissociation of mutagenic and other toxic properties from schistosomicides

17 October 2022

81

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Respiratory metabolism of parasitic helminths without participation of the cytochrome system.

17 October 2022

82

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Biochemical effects of schistosomicides

17 October 2022

83

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

Molecular Pharmacology

84

6

532

Bueding

1970

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Content and distribution of glycogen in Schistosoma mansoni

17 October 2022

85

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The relationship between inhibition of phosphofructokinase activity and the mode of action of trivalent organic antimonials on Schistosoma mansoni

17 October 2022

88

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of 2-methyl-1,4-naphthoquinone on glycolysis of Schistosoma mansoni

17 October 2022

91

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of respiratory inhibition on Schistosoma mansoni

17 October 2022

92

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

GLUCOSAMINE KINASE OF SCHISTOSOMA MANSONI.

17 October 2022

93

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Some physiological, biochemical, and morphologic effects of tris (p-aminophenyl) carbonium salts (TAC) on Schistosoma mansoni

17 October 2022

94

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Inhibition by metrifonate and dichlorvos of cholinesterases in schistosomes

17 October 2022

96

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Tris(p-aminophenyl) carbonium salts in the treatment of schistosomiasis in Nyasaland

17 October 2022

97

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Efficacy of a 2-Phenyl Quinoline against Experimental Schistosoma mansoni Infections in Mice and Monkeys

17 October 2022

98

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Inhibition of Egg Production of Schistosoma mansoni in Mice Treated with Nicarbazin

17 October 2022

99

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A new approach to helminthiasis control: the use of an organophosphorous compound

17 October 2022

104

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Bacteria in the “Curative” Effect of Hemolymph of Biomphalaria Glabrata on Schistosoma Mansoni-Infected Mice

17 October 2022

110

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

THE SUCCESSFUL USE OF ANTIMONY IN BILHARZIOSIS

17 October 2022

112

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Dosage schemes and dosage response of niridazole in schistosomiasis

17 October 2022

115

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Mutagenicity of hycanthone in mammalian cells

17 October 2022

119

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of cortisone on natural immunity to Schistosoma mansoni in mice

17 October 2022

121

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Clinical trial of hycanthone in Schistosomiasis mansoni in St. Lucia.

17 October 2022

124

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Some notes on the maintenance and breeding of schistosome vectors in Great Britain, with special reference to Planorbis guadaloupensis Sowerby

17 October 2022

131

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effects of Guinea-Pig Kidney Extract Positive for Forssman Antigen on Adult Schistosoma Mansoni in Mice *

17 October 2022

132

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The Effects of Rhesus-Monkey Erythrocyte Stromata and Hemolysate in Experimental Murine Schistosomiasis Mansoni *

17 October 2022

133

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental studies on the chemosterilization of Schistosoma mansoni

17 October 2022

144

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Suppressive management of schistosomiasis with antimony dimercaptosuccinate

17 October 2022

145

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Treatment of Schistosoma mansoni infection with rhesus monkey stromata: two unsuccessful attempts

17 October 2022

149

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effect of metrifonate in vitro on Schistosoma haematobium and S. mansoni adults

17 October 2022

151

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of anaesthetics on mature infections of Schistosoma mansoni in the white mouse.

17 October 2022

154

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effects of Tris(p-Aminophenyl)-Carbonium Salts and Related Compounds on Experimental Schistosomiasis and Paragonimiasis

17 October 2022

159

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

(4-(AMINOALKYLAMINO)-1-NAPHTHYLAZO)HETEROCYCLIC COMPOUNDS, A NOVEL CLASS OF SCHISTOSOMICIDES

17 October 2022

160

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

SYNTHETIC SCHISTOSOMICIDES. IV. 5-(4-(2-DIETHYLAMINOETHYLAMINO)-1-NAPHTHYLAZO)URACIL AND RELATED (4-(AMINOALKYLAMINO)-1-NAPHTHYLAZO)HETEROCYCLIC COMPOUNDS

17 October 2022

161

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

SYNTHETIC SCHISTOSOMICIDES. V. N-(MONO-AND DIALKYLAMINOALKYL)-1,4-NAPHTHALENEDIAMINES AND RELATED NAPHTHYLAMINES

17 October 2022

162

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

SYNTHETIC SCHISTOSOMICIDES. VI. 4-SUBSTITUTED 1-(DIALKYLAMINOALKYLAMINO)NAPHTHALENES

17 October 2022

163

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthetic Schistosomicides. VIII. N-Mono- and N,N-Dialkyl-N'-(4-arylazo-1-naphthyl)alkylenediamines and Related Compounds1

17 October 2022

164

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthetic schistosomicides. XIV. 1,4-Naphthoquinone mono(O-acyloximes), 4-amino-1,2-naphthoquinones, 2-amino-3-chloro-1,4-naphthoquinones, and other naphthoquinones

17 October 2022

165

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthetic schistosomicides. XVII. N-(benzylidene and cinnamylidene)-N'-[2-(diethylamino)ethyl]-1,4-naphthalenediamines and related Schiff bases

17 October 2022

166

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Antimalarial and antischistosomal effects of alpha,alpha,alpha,alpha',alpha',alpha'-hexachloroxylene derivatives and related halogenated hydrocarbons

17 October 2022

167

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Selective Antagonism of Arsenicals and Antimonials

17 October 2022

168

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Chemotherapeutic and Toxicological Properties of Antimonyl Tartrate-Dimethylcysteine Chelates

17 October 2022

169

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosoma mansoni: Early antimonial treatment of infected mice

17 October 2022

170

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Trivalent sodium antimony gluconate in the treatment of Schistosomiasis

17 October 2022

171

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Metabolism of niridazole in various species, including man.

17 October 2022

176

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosomiasis and some of its problems

17 October 2022

179

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Treatment of urinary schistosomiasis with Astiban and with Astiban acid in oil: a quantitative evaluation

17 October 2022

181

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Astiban therapy of Schistosoma mansoni infection: a quantitative evaluation.

17 October 2022

182

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Hepatotoxicity after treatment of schistosomiasis with hycanthone

17 October 2022

183

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Treatment with hycanthone of Egyptian farmers infected withSchistosoma haematobiumandS. mansoni

17 October 2022

184

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A study of the vector-parasite relationships in Schistosoma mansoni

17 October 2022

187

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A study on the comparative susceptibility of snail vectors to strains of Schistosoma mansoni

17 October 2022

188

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Treatment of urinary schistosomiasis with trichlorophone

17 October 2022

189

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Oral tartar emetic in the treatment of schistosomiasis

17 October 2022

190

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Preliminary studies on the development of Schistosoma mansoni in rhesus monkeys following different regimens of infection

17 October 2022

192

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies with the schistosomicide oxamniquine (UK-4271) I. Activity in rodents and in vitro

17 October 2022

193

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Comparative studies of the action of mirasan, lucanthone, hycanthone and niridazole againstSchistosoma mansoniin mice

17 October 2022

194

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The action of UK 3883, a novel 2-aminomethyltetra-hydroquinoline derivative, against mature schistosomes in rodents and primates

17 October 2022

195

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The control of immatureSchistosoma mansoniin mice by UK 3883, a novel 2-aminomethyltetrahydroquinoline derivative

17 October 2022

196

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies with the schistosomicide oxamniquine (UK-4271). II. Activity in primates.

17 October 2022

197

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The evaluation of drugs in human schistosomiasis

17 October 2022

200

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effect of a single dose of TWSb in urinary bilharziasis: suggestions for a suppressive management of bilharziasis

17 October 2022

202

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Histochemical localization of esterase activity in schistosomes

17 October 2022

205

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The sites of (1-14C) glucose assimilation in Schistosoma haematobium

17 October 2022

206

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Clinical evaluation of antischistosomal drugs

17 October 2022

217

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Amphotericin B in the Chemotherapy of Experimental Schistosomiasis mansoni in Swiss Mice

17 October 2022

222

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Hycanthone: a frameshift mutagen.

17 October 2022

228

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Chemotherapeutic nitroheterocycles. Antischistosomal properties of nitrofurylvinyl and nitrothienylvinyl heterocycles

17 October 2022

229

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Selective Uptake of an Antibilharzial Nitrothiazole Compound by Schistosoma mansoni

17 October 2022

230

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Chemotherapeutic studies with laboratory infections of Schistosoma mansoni.

17 October 2022

231

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Use of the oogram to reveal the effect of a nitrofurylacrylamide on the eggs of Schistosoma mansoni

17 October 2022

233

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosomicidal 5-nitro-4-thiazolines

17 October 2022

240

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 2.

17 October 2022

241

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Antiparasitic 5-nitrothiazoles and 5-nitro-4-thiazolines. 3

17 October 2022

242

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Chemosterilization of Schistosoma mansoni

17 October 2022

243

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Therapeutic effects of Ambilhar (niridazole) in children and adults withSchistosoma mansoniinfection

17 October 2022

246

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemoprophylaxis against schistosomiasis. I. Introduction and rationale.

17 October 2022

248

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemoprophylaxis against schistosomiasis. II. Stage I comparison of lucanthone, hycanthone, niridazole and oxamniquine (UK 4271)

17 October 2022

249

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Trial of ambilhar, a nitrothiazole derivative, in S. mansoni infections in Tanzania.

17 October 2022

250

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

THE SUSCEPTIBILITY OF THREE STRAINS OF AUSTRALORBIS GLABRATUS TO SCHISTOSOMA MANSONI FROM BRAZIL AND PUERTO RICO

17 October 2022

253

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemotherapy of Schistosomiasis mansoni

17 October 2022

260

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Quantitative oogram method in Cebus monkeys experimentally infected with Schistosoma mansoni

17 October 2022

264

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemotherapy of schistosomiasis. II. Laboratory and clinical trials with A-16612, a piperazine derivative

17 October 2022

266

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Preliminary clinical trials with hycanthone, a new antischistosomal agent

17 October 2022

267

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Further clinical trials with hycanthone, a new antischistosomal agent

17 October 2022

269

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces

17 October 2022

270

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Evaluation of Kato's quantitative method through the recovery of Schistosoma mansoni eggs added to human feces

17 October 2022

271

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

277

25

1919

Kaump

1965

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The metabolism of a new schistosomicide 2-isopropylaminomethyl-6-methyl-7-nitro-1,2,3,4-tetrahydroquinoline (UK 3883).

17 October 2022

278

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

British Journal of Pharmacology

17 October 2022

281

22

342

Khayyal

1964

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

SIGNIFICANCE OF WORM SHIFTS IN EXPERIMENTAL SCHISTOSOMIASIS MANSONI, WITH EMPHASIS ON THE ACTION OF ANAESTHETICS.

17 October 2022

282

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental studies on the therapy of schistosomiasis

17 October 2022

287

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMA MANSONI INFECTIONS WITH A NITRO-THIAZOLE DERIVATIVE, CIBA 32,644-BA

17 October 2022

292

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Proceedings of a symposium on the evaluation of drugs for tropical diseases. 3. Schistosomiasis. Some criteria for the evaluation of schistosomicidal compounds

17 October 2022

293

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMA MANSONI INFECTIONS WITH A NITRO-THIAZOLE DERIVATIVE, CIBA 32,644-BA

17 October 2022

294

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

[A new compound active against bilharziasis and amebiasis]

17 October 2022

295

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMA MANSONI INFECTIONS WITH A NITRO-THIAZOLE DERIVATIVE, CIBA 32,644-BA

17 October 2022

296

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

NOTES ON ONE THOUSAND CASES OF BILHARZIASIS TREATED BY ANTIMONY TARTRATE

17 October 2022

307

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Lucanthone hydrochloride in the treatment of Schistosoma mansoni infection

17 October 2022

310

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The relative chemotherapeutic efficacy of a nitrovinylfuran (SQ 18,506) against immature and mature stages of Schistosoma mansoni.

17 October 2022

314

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Cellular Resistance against Schistosomula of Schistosoma Mansoni in Macaca Mulatta Monkeys Following Prolonged Infections *

17 October 2022

317

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A STUDY OF THE DISTRIBUTION AND FATE OF ANTIMONY WHEN USED AS TARTAR EMETIC AND FUADIN IN THE TREATMENT OF AMERICAN SOLDIERS WITH SCHISTOSOMIASIS JAPONICA.

17 October 2022

318

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies on chemotherapy of experimental schistosomiasis. V. Enhancement of the schistosomacidal activity of tartar emetic and stibophen by glycerin

17 October 2022

321

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Acute haemolysis with Ambilhar treatment in glucose-6-phosphate dehydrogenase deficiency

17 October 2022

325

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Mechanism of Action of Thiosinamine, an Egg Suppressive Agent in Schistosomiasis

17 October 2022

327

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A report on the side effects of Ambilhar (niridazole) and the effect of antihistamines and aspirin on these reactions

17 October 2022

328

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Clinical trial with Ambilhar in Schistosoma mansoni infections in Tanzania

17 October 2022

329

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Kinetics of lactic dehydrogenases of Schistosoma mansoni and of rabbit muscle

17 October 2022

335

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

British Journal of Pharmacology

17 October 2022

336

9

459

Mansour

1954

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effect of a specific antiserum on the activities of lactic dehydrogenase of mammalian muscle and of Schistosoma mansoni

17 October 2022

337

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Evaluation of Kato thick-smear technique for quantitative diagnosis of helminth infections

17 October 2022

344

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Mating of Schistosoma mansoni in Vitro

17 October 2022

353

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Evolution and characteristics of Schistosoma mansoni eggs laid in vitro

17 October 2022

354

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Unusual oogram pattern in mice after niridazole treatment

17 October 2022

357

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Development of Schistosoma mansoni in the peritoneal cavity of mice

17 October 2022

358

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A comparison of common laboratory animals as experimental hosts for Schistosoma mansoni

17 October 2022

359

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental infection of Bulinus truncatus with Schistosoma haematobium.

17 October 2022

360

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Teratogenicity of Hycanthone in Mice

17 October 2022

361

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A Thiamine (Vitamin B1 or Aneurin) antimetabolite as a potent schistosomicidal agent

17 October 2022

364

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experiments with some miracil, acridine, and diamidine compounds on Schistosoma mansoni infections in baboons

17 October 2022

370

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Maturation of Schistosome Eggs in vitro

17 October 2022

371

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Immune Opsonins in Schistosoma Infestations

17 October 2022

373

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

OBSERVATIONS ON CORTICOSTEROID TREATMENT OF SCHISTOSOMIASIS IN HAMSTERS AND BABOONS

17 October 2022

374

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Monoamine oxidase activity of shistosoma mansoni

17 October 2022

376

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Our knowledge of immunity to schistosomiasis.

17 October 2022

382

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Serological reactions against egg antigens as an aid in the evaluation of therapy in schistosomiasis

17 October 2022

384

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

An efficient method for exposure of mice to cercariae of Schistosoma mansoni

17 October 2022

385

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Bacterial invasion of Schistosomes.

17 October 2022

392

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies on the effects of bacteria on experimental schistosome infections in animals

17 October 2022

393

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Clinical experiences with antimonyl-dimethylcysteino-tartrate (NAP) in a rural population infected withSchistosoma mansoni

17 October 2022

399

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

(CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI IN MICE AND HAMSTERS WITH AMPHOTERICIN B.)

17 October 2022

401

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Method for isolating schistosome granulomas from mouse liver

17 October 2022

402

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

EARLY EFFECT OF TRIS (P-AMINOPHENYL) CARBONIUM PAMOATE ON THE EGG LAYING OF SCHISTOSOMA MANSONI

17 October 2022

403

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

THE OOGRAM METHOD FOR THE SCREENING OF DRUGS IN SCHISTOSOMIASIS MANSONI

17 October 2022

404

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A Simple Method for Collecting Egg Clutches of Biomphalaria glabrata (Australorbis glabratus) and for Rearing Newly Hatched Snails

17 October 2022

405

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemotherapy of Schistosomiasis mansoni

17 October 2022

406

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

New Approach to the Screening of Drugs in Experimental Schistosomiasis Mansoni in Mice *

17 October 2022

412

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Infection of the golden hamster with Schistosoma mansoni cercariae through the cheek pouch

17 October 2022

414

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

RECTAL BIOPSY AND MUCOSAL CURETTAGE IN CEBUS MONKEYS EXPERIMENTALLY INFECTED WITH SCHISTOSOMA MANSONI AND SCHISTOSOMA JAPONICUM

17 October 2022

415

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Oogram studies with Hycanthone, a new antischistosomal agent.

17 October 2022

417

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Experimental chemotherapy of schistosomiasis. I. Laboratory trials with R.D. 12,869, a new aminoquinoline

17 October 2022

418

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

HYDROMERMIS ITASCENSIS SP. N. (NEMATODA: MERMITHIDAE) A PARASITE OF GLYPTOTENDIPES LOBIFERUS (SAY) (DIPTERA:CHIRONOMIDAE) AND THE TAXONOMIC STATUS OF GASTROMERMIS

17 October 2022

423

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Schistosoma mansoni: Mouse mortality test system for mass screening for prophylactic drugs

17 October 2022

431

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

British Journal of Pharmacology

17 October 2022

432

10

191

Raison

1954

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The schistosomicidal activity of symmetrical diaminodiphenoxyalkanes

17 October 2022

434

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Initial experiences with niridazole

17 October 2022

435

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A New Series of 2-Aminomethyltetrahydroquinoline Derivatives displaying Schistosomicidal Activity in Rodents and Primates

17 October 2022

438

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A simple procedure for recovering schistosome eggs in mass from tissues

17 October 2022

439

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Biological potentials of Australorbis glabratus: growth and maturation

17 October 2022

440

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Biological Potentials of Australorbis Glabratus: Life Span and Reproduction

17 October 2022

441

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The influence of infection intensity of Schistosoma mansoni on resistance against existing and subsequent infections in Macaca mulatta.

17 October 2022

442

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

Molecular Pharmacology

443

6

604

Robinson

1970

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Egg-Laying bySchistosoma Mansoni in Vitro

17 October 2022

444

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Treatment of schistosomiasis mansoni with antimony lithium thiomalate (Anthiomaline); final report.

17 October 2022

454

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies on Immunity to Schistosoma Mansoni—II. The Circumoval Precipitin Reaction to S. Mansoni in Mice Treated with Stibophen

17 October 2022

455

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The circumoval precipitin test in schistosoma mansoni. A study of 300 patients

17 October 2022

456

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Hycanthone Resistance: Development in Schistosoma mansoni

17 October 2022

457

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A new active metabolite of "Miracil D".

17 October 2022

459

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Preparation and Schistosomicidal Activity of Some 4-Hydroxymethyl-3-chloroanilines

17 October 2022

460

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effects of tubercidin and its ribonucleotides on various metabolic pathways in Schistosoma mansoni.

17 October 2022

461

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effect of CIBA 32,644-Ba in the treatment of 1,059 cases of vesical and intestinal schistosomiasis

17 October 2022

463

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

THERAPEUTIC STUDIES ON DEHYDROEMETINE IN SCHISTOSOMIASIS

17 October 2022

467

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A System for Mass Producing the Snail Australorbis glabratus and Cercariae of Schistosoma mansoni

17 October 2022

472

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

Pharmacological Reviews

474

18

871

Saz

1966

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Conditions for drug testing in experimental schistosomiasis mansoni in mice

17 October 2022

476

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Screening of drugs in experimental schistosomiasis mansoni in mice

17 October 2022

477

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of drugs during earliest stages of experimental schistosomiasis mansoni in mice

17 October 2022

478

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Comparison of several antimonials in the treatment of experimental schistosomiasis mansoni in mice

17 October 2022

479

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

OBSERVATIONS ON AMINO ACID METABOLISM OF SCHISTOSOMA MANSONI IN A CHEMICALLY DEFINED MEDIUM

17 October 2022

483

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

RECENT DEVELOPMENTS IN THE UNDERSTANDING OF AMINO-ACID AND PROTEIN METABOLISM BY SCHISTOSOMA MANSONI IN VITRO

17 October 2022

484

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies in arginine metabolism by schistosomes. I. Arginine uptake and lysis by Schistosoma mansoni

17 October 2022

485

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of hycanthone, niridazole, and antimony tartrate on schistosome motility *

17 October 2022

486

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Purine metabolism in Schistosoma mansoni.

17 October 2022

487

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Pathways of nucleotide metabolism in Schistosoma mansoni. II. Disposition of adenosine by whole worms

17 October 2022

488

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Pathways of nucleotide metabolism in Schistosoma mansoni. 3. Identification of enzymes in cell-free extracts

17 October 2022

489

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effects of hycanthone on rapidly proliferating cells

17 October 2022

492

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Lipid fractions in adultSchistosoma mansoni

17 October 2022

499

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The isolation of viable schistosome eggs by a digestion technique

17 October 2022

500

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms

17 October 2022

501

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Effect of niridazole on erythropoiesis of Congolese treated for schistosomiasis and amoebiasis

17 October 2022

502

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effects of temperature, light and salinity upon the hatching of the ova of Schistosoma mansoni

17 October 2022

506

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The treatment of experimental schistosomiasis in mice; sexual maturity and drug response

17 October 2022

509

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Laboratory evaluation of schistosomicidal substances

17 October 2022

512

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Pathways of nucleotide metabolism in Schistosoma mansoni. IV. Incorporation of adenosine analogs in vitro

17 October 2022

513

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: PROPHYLACTIC AND PROTECTIVE ACTIVITY OF CLINICALLY ACTIVE COMPOUNDS IN MICE AND HAMSTERS

17 October 2022

515

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: PROPHYLACTIC, PROTECTIVE AND THERAPEUTIC ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID IN MICE AND HAMSTERS

17 October 2022

516

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: INFLUENCE OF DIMERCAPTOSUCCINIC ACID ON THE TOXICITY AND ANTISCHISTOSOMAL ACTIVITY OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND OTHER ANTIMONY COMPOUNDS IN MICE

17 October 2022

517

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effects of niridazole in experimental schistosomiasis

17 October 2022

520

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Possible snail hosts of human schistosomes in the United States

17 October 2022

522

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The effect of penicillamine in the treatment of experimental schistosomiasis with tartar emetic

17 October 2022

524

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

A comparison of the susceptibility to niridazole of two geographical strains of Schistosoma mansoni in mice with a note on the susceptibility of S. mattheei

17 October 2022

525

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

CHEMOTHERAPY OF EXPERIMENTAL SCHISTOSOMIASIS MANSONI: DISTRIBUTION OF ANTIMONY-124 IN MICE AND HAMSTERS AFTER A SINGLE DOSE OF SODIUM ANTIMONY DIMERCAPTOSUCCINATE AND ANTIMONY DIMERCAPTOSUCCINIC ACID

17 October 2022

528

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Laboratory studies on the effects of tris(p-aminophenyl)-carbonium salts, tris(p-aminophenyl)methanol, and lucanthone hydrochloride against Schistosoma mansoni

17 October 2022

529

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies of a proteolytic enzyme from Schistosoma mansoni

17 October 2022

531

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Suppression of Hepatosplenic Schistosomiasis Mansoni in Mice by Nicarbazin, a Drug That Inhibits Egg Production by Schistosomes

17 October 2022

538

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Investigations on the antibilharzial action of miracil D

17 October 2022

541

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Studies on schistosomiasis. 14. Effects of cortisone upon the Schistosoma mansoni burden in mice

17 October 2022

542

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Organophosphorus compounds as schistosomicides

17 October 2022

544

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthetic schistosomicides. IX. N-(dialkylaminoalkyl)-4-nitroso-1-naphthylamines

17 October 2022

545

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

2-(alkyl- and arylamino)-5-nitrothiazole derivatives with antiamebic, antitrichomonal, and antimalarial properties

17 October 2022

546

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Synthetic schistosomicides. XVIII. N-(4-[[2-(Diethylamino)ethyl]amino]-1-naphthyl)amides, N-[5,6,7,8-tetrahydro-4-[(3-piperidinopropyl)amino]-1-naphthyl]amides, and related amide and urea derivatives

17 October 2022

547

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

1-Alkyl-3-(3-alkyl-5-nitro-4-thiazolin-2-ylidene)ureas and related compounds as schistosomicides

17 October 2022

548

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

Novel schistosomicides. S-2-((2-(2-thiazolylcarbamoyl)ethyl)amino)ethyl hydrogen thiosulfate and related compounds

17 October 2022

549

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

An 18-month study of the parasitologic and tumorigenic effects of hycanthone in Schistosoma mansoni-infected and noninfected mice

17 October 2022

554

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

The role of ingested hemoglobin in the nutrition of Schistosoma mansoni

17 October 2022

560

1 reference

https://api.crossref.org/works/10.1016/S1054-3589(08)60184-2

17 October 2022

Identifiers

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=18911

17 October 2022

1 reference